Abstract:OBJECTIVE:To investigate an inhibitive effect of the chitosan nanoparticles with the proliferation cell nuclear antigen (PCNA)-antisense oligo deoxy nucleotides (ASODN) on the intimal cell proliferation after the vein grafting. METHODS:Fifty-four male SD rats, weighing 450-600 g, were randomly divided in the experimental group and the control group of 27 rats each. In the experimental group, the chitosan nanoparticles with PCNA-ASODN were infused into the anastomosis segment of the right jugular artery and vein; then, the anastomosis segment was transplanted to the jugular artery on the same side. The rats in the control group were infused with normal saline by the same procedures. There were 24 rats in each group which used to experiment. The hemodynamic data were obtained from the Doppler ultrasound examinations at 1, 2, 3 and 4 weeks. The specimens were taken. Immunohistochemistry, Western-blot, and blood-vessel-wall histopathology were performed at the different week points. RESULTS:There was no significant difference in the thrombogenesis rate between the experimental group and the control group (3/27 vs. 3/27, P > 0.05). During the 4-week observation, PCNA Western-blot showed that the PCNA level was lower in the grafted vein and the anastomosis segment in the experimental group than in the control group. The indexes of the PCNA-postive proliferating cells in the intimal area (0.13% +/- 0.11%, 0.79% +/- 0.28%, 0.45% +/- 0.29%, 0.43% +/- 0.25%) and the medial area (1.90% +/- 0.84%, 2.11% +/- 0.98%, 2.48% +/- 0.77%, 2.17% +/- 0.36%) were significantly decreased at 1, 2, 3 and 4 weeks in the experimental group when compared with those in the control group (P < 0.05). The lumen areas in the grafted vein (88.71 +/- 16.96, 95.98 +/- 21.44, 88.48 +/- 32.81, 97.86 +/- 34. 11 microm2) and the anastomosis segment (41.49 +/- 3.34, 45.15 +/- 11.65, 46.27 +/- 8.90, 51.62 +/- 8.85 microm2) were significantly greater in the experimental group than in the control group (P < 0.05). The ratios of the initmal area to the medial area in the grafted vein (22.73% +/- 3.11%, 32.40% +/- 4.55%, 45.14% +/- 3.19%, 45.70% +/- 5.01%) and the anastomsis segment (41.49% +/- 3.34%, 45.15% +/- 11.65%, 46.27% +/- 8.90%, 51.62% +/- 8.85%) were significantly smaller in the experimental group than in the control group (P < 0.05). The maximum velocities (Vmax) of the blood flow in the grafted vein and the anastomsis segment were almost the same in the two groups at 1 week, but had different changes at the next 3 week-points. In the control group, the Vmax of the blood flow gradually increased and at 3 weeks it reached the peak point; however, at 4 weeks it decreased. In the experimental group, the Vmax of the blood flow gradually decreased, and at 3 weeks it decreased to the lowest point; however, at 4 weeks it increased. So, at 4 weeks the Vmax of the blood flow in the grafted vein and the anastomsis segment was almost the same in the two groups. There was no significant difference in the Vmax of the blood flow between the two groups (P > 0.05), but in the same group there was a significant difference at the different time points. CONCLUSION:The chitosan nanoparticles with PCNA-ASODN can effectively inhibit the intimal cell proliferation after the grafting of the blood vessel, so that the neointimal thickening can be prevented.

C-myc antisense oligodeoxynucleotides transferred by soluble stent preventing vein graft stenosis

C-myc antisense oligodeoxynucleotides transferred by soluble stent inhibit the expression of c-myc mRNA

Effect on the Expression of C-myc and Proliferating Cell Nuclear Antigen of Vein Grafts Transferred by C-myc Antisense Oligodeoxynucleotides of Soluble Stent

Co-transfection of tPA gene and c-myc antisense oligodeoxynucleotides for the prevention of intimal hyperplasia of rabbit auto-transplantion artery

MicroRNA-221 sponge therapy attenuates neointimal hyperplasia and improves blood flows in vein grafts

The influence of basic fibroblast growth factor in slow-release microcapsules on implanted vein graft-an experimental study

Polymer-based Delivering of Shrna to Rabbit Aortic Smooth Muscle Cells Suppressed the Expression of IGF-1R in Vitro and in Vivo.

Controlled release of siRNA nanoparticles loaded in a novel external stent prepared by emulsion electrospinning attenuates neointima hyperplasia in vein grafts

Gene therapy for vein graft restenosis

A Soft, Conductive External Stent Inhibits Intimal Hyperplasia in Vein Grafts by Electroporation and Mechanical Restriction

MicroRNA-365 Promotes the Contractile Phenotype of Venous Smooth Muscle Cells and Inhibits Neointimal Formation in Rat Vein Grafts.

Effect of fibrin glue associated with antisense to PCNA on preventing restenosis of vein grafts

CTLA4-Ig ameliorates the immune response of the portal venous allografts in mice

MicroRNA-146a sponge therapy suppresses neointimal formation in rat vein grafts.

Nitric oxide improves regeneration and prevents calcification in bio-hybrid vascular grafts via regulation of vascular stem/progenitor cells

A Small-Diameter Vascular Graft Promotes Rapid and Benign Remodeling of the Neointima Through Dual Release of Nitric Oxide and Hydrogen Sulfide

Effect of Co-Transfection of VEGF and PCNA-ASODN on Restenosis after Percutaneous Transluminal Coronary Angioplasty

Local Tansfection of Antisense Transforming Growth Factor-Β1 Carried by Nanoparticles Inhibits Intimal Hyperplasia in Autogenous Vein Grafts in Rats

Effects of Haemopoietic Stem Cell Mobilization on Improving Vein Graft Patency

[Inhibition of Intimal Proliferation after Vein Grafting by Chitosan Nanoparticle with Proliferation Cell Nuclear Antigen-Antisense Oligo Deoxy Nucleotides].

[The Study on Platelet-Derived Growth Factor and Proliferating Cell Nuclear Antigen Antisense Oligodeoxynucleotides Together Inhibiting the Stenosis of Transplanted Vascular].